Literature DB >> 29487172

Does HIV pre-exposure prophylaxis use lead to a higher incidence of sexually transmitted infections? A case-crossover study of men who have sex with men in Los Angeles, California.

Matthew R Beymer1,2, Michelle A DeVost2, Robert E Weiss3, Rhodri Dierst-Davies4, Chelsea L Shover2, Raphael J Landovitz1,5, Corinne Beniasians2, Ali J Talan2, Risa P Flynn2, Robyn Krysiak2, Kayla McLaughlin2, Robert K Bolan2.   

Abstract

BACKGROUND: Pre-exposure prophylaxis (PrEP) is an effective method for reducing HIV incidence among at-risk populations. However, concerns exist over the potential for an increase in STIs following PrEP initiation. The objective of this study is to compare the STI incidence before and after PrEP initiation within subjects among a cohort of men who have sex with men in Los Angeles, California.
METHODS: The present study used data from patients who initiated PrEP services at the Los Angeles LGBT Center between October 2015 and October 2016 (n=275). A generalised linear mixed model was used with a case-crossover design to determine if there was a significant difference in STIs within subjects 365 days before (before-PrEP period) and 365 days after PrEP initiation (after-PrEP period).
RESULTS: In a generalised linear mixed model, there were no significant differences in urethral gonorrhoea (P=0.95), rectal gonorrhoea (P=0.33), pharyngeal gonorrhoea (P=0.65) or urethral chlamydia (P=0.71) between periods. There were modest increases in rectal chlamydia (rate ratio (RR) 1.83; 95% CI 1.13 to 2.98; P=0.01) and syphilis diagnoses (RR 2.97; 95% CI 1.23 to 7.18; P=0.02).
CONCLUSIONS: There were significant increases in rectal chlamydia and syphilis diagnoses when comparing the periods directly before and after PrEP initiation. However, only 28% of individuals had an increase in STIs between periods. Although risk compensation appears to be present for a segment of PrEP users, the majority of individuals either maintain or decrease their sexual risk following PrEP initiation. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  chlamydia infection; gay men; prophylaxis; sexual health; syphilis

Mesh:

Year:  2018        PMID: 29487172      PMCID: PMC6482844          DOI: 10.1136/sextrans-2017-053377

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  23 in total

1.  Does HIV Pre-Exposure Prophylaxis Modify the Effect of Partnership Characteristics on Condom Use? A Cross-Sectional Study of Sexual Partnerships Among Men Who Have Sex with Men in San Francisco, California.

Authors:  Maximo R Prescott; Jaclyn Hern; Maya Petersen; Glenn-Milo Santos
Journal:  AIDS Patient Care STDS       Date:  2019-04       Impact factor: 5.078

2.  Decisional Balance and Contemplation Ladder to Support Interventions for HIV Pre-Exposure Prophylaxis Uptake and Persistence.

Authors:  Steven A John; H Jonathon Rendina; Tyrel J Starks; Christian Grov; Jeffrey T Parsons
Journal:  AIDS Patient Care STDS       Date:  2019-01-17       Impact factor: 5.078

Review 3.  Confronting Rising STIs in the Era of PrEP and Treatment as Prevention.

Authors:  Meena S Ramchandani; Matthew R Golden
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

4.  Challenges in optimizing preexposure prophylaxis development, engagement, and access for HIV prevention.

Authors:  Eileen P Scully; Ethel D Weld; Joel N Blankson
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 5.  Review of Real-World Implementation Data on Emtricitabine-Tenofovir Disoproxil Fumarate as HIV Pre-exposure Prophylaxis in the United States.

Authors:  Jessica L Adams; Karishma Shelley; Melanie R Nicol
Journal:  Pharmacotherapy       Date:  2019-04-01       Impact factor: 4.705

6.  Sexually transmitted infections and sexual behaviors of men who have sex with men in an American Deep South PrEP clinic.

Authors:  Ronnie M Gravett; Andrew O Westfall; Edgar T Overton; Kachina Kudroff; Christina A Muzny; Ellen F Eaton
Journal:  Int J STD AIDS       Date:  2020-01-28       Impact factor: 1.359

7.  HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.

Authors:  Suzan M Walters; Alex H Kral; Kelsey A Simpson; Lynn Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2020-09-23       Impact factor: 2.164

8.  Social and behavioural research prospects for sexually transmissible infection prevention in the era of advances in biomedical approaches.

Authors:  Matthew Hogben; Patricia J Dittus; Jami S Leichliter; Sevgi O Aral
Journal:  Sex Health       Date:  2020-04       Impact factor: 2.706

9.  Gastroenteritis in Men Who Have Sex With Men in Seattle, Washington, 2017-2018.

Authors:  Kira L Newman; Gretchen Snoeyenbos Newman; Robert J Cybulski; Ferric C Fang
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

10.  Differences in sexually transmitted infection risk comparing preexposure prophylaxis users and propensity score matched historical controls in a clinic setting.

Authors:  Michalina A Montaño; Julia C Dombrowski; Sayan Dasgupta; Matthew R Golden; Lisa E Manhart; Lindley A Barbee; Ann Duerr; Christine M Khosropour
Journal:  AIDS       Date:  2019-09-01       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.